Prospective assessment of psychological and vasomotor side effects of testosterone deprivation and assessment of ageing males’ symptoms scale in prostate cancer patients

ottingham University Hospitals NHS Trust0 个研究点目标入组 150 人开始时间: 2021年7月27日最近更新: 2021年8月10日

适应症

试验速览

暂无简介。

•1. Patients with prostate cancer starting LHRH agonist therapy, irrespective of stage
•2. Ability to give informed consent
•3. Performance status 0-2
•4. Life expectancy should be more than 6 months

•1. Past or present history of psychiatric problem
•2. If a patient scores greater than 11 on the baseline Hospital and Anxiety Scale they will be offered anti-depressant drug treatment and/or a psychiatric referral. In addition they will be asked if they wished to continue in the study. If the patients do not wish to continue at this stage the researchers would not collect any further quality of life information from them
•3. Concurrent steroid therapy or treatment with any other antipsychotic/antidepressant/sedative drugs
•4. Brain metastases
•5. Concurrent radiotherapy
•6. Major surgery in last 6 months, e.g. prostatectomy, colectomy etc
•7. Major medical illness in last 6 months e.g. pulmonary embolism, myocardial infarction, cerebrovascular accident etc

发起方

ottingham University Hospitals NHS Trust